GB201419102D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201419102D0
GB201419102D0 GBGB1419102.7A GB201419102A GB201419102D0 GB 201419102 D0 GB201419102 D0 GB 201419102D0 GB 201419102 A GB201419102 A GB 201419102A GB 201419102 D0 GB201419102 D0 GB 201419102D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1419102.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Ltd filed Critical Imperial Innovations Ltd
Priority to GBGB1419102.7A priority Critical patent/GB201419102D0/en
Publication of GB201419102D0 publication Critical patent/GB201419102D0/en
Priority to PCT/GB2015/053217 priority patent/WO2016067012A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1419102.7A 2014-10-27 2014-10-27 Novel compounds Ceased GB201419102D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1419102.7A GB201419102D0 (en) 2014-10-27 2014-10-27 Novel compounds
PCT/GB2015/053217 WO2016067012A1 (en) 2014-10-27 2015-10-27 Compounds as sirt2 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1419102.7A GB201419102D0 (en) 2014-10-27 2014-10-27 Novel compounds

Publications (1)

Publication Number Publication Date
GB201419102D0 true GB201419102D0 (en) 2014-12-10

Family

ID=52103468

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1419102.7A Ceased GB201419102D0 (en) 2014-10-27 2014-10-27 Novel compounds

Country Status (2)

Country Link
GB (1) GB201419102D0 (en)
WO (1) WO2016067012A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201234A (en) * 2017-07-17 2020-05-26 南京瑞捷医药科技有限公司 Novel compounds and their use as ACC inhibitors
CN111205210A (en) * 2020-02-26 2020-05-29 上海博黑生物科技有限公司 Synthetic method of 2-methyl pyrroline
CN112939955B (en) * 2021-03-05 2022-10-21 朗捷睿(苏州)生物科技有限公司 8- (pyridine amide) substituted coumarin compound and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465739B2 (en) * 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7524853B2 (en) * 2003-06-10 2009-04-28 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
DK2024372T3 (en) * 2006-04-26 2010-09-20 Hoffmann La Roche Thieno [3,2-d] pyrimidine derivative suitable as P13K inhibitor

Also Published As

Publication number Publication date
WO2016067012A1 (en) 2016-05-06

Similar Documents

Publication Publication Date Title
IL250345A0 (en) Novel compounds
IL250592A0 (en) Novel compounds
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
PT3134402T (en) 4-amino-imidazoquinoline compounds
GB201417011D0 (en) Novel compounds
GB201417094D0 (en) Novel compounds
GB201417018D0 (en) Novel compounds
GB201402431D0 (en) Compounds
SG11201606693SA (en) Novel compounds
GB201405991D0 (en) Novel compounds
GB201411239D0 (en) Novel compounds
GB201411236D0 (en) Novel compounds
GB201404987D0 (en) Compounds
GB201404002D0 (en) Novel compounds
GB201406956D0 (en) Compounds
GB201406591D0 (en) Compounds
IL248983A0 (en) Novel compounds
GB201419102D0 (en) Novel compounds
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
ZA201605726B (en) Novel compounds
GB201421834D0 (en) Novel compounds
GB201421784D0 (en) Novel compounds
GB201417041D0 (en) Novel compounds
GB201417021D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)